Seizures or fits
A first seizure in an adult always warrants brain imaging.
There are over 120 types of brain tumour — benign and malignant, primary and metastatic — and each calls for a different plan. AARO's neuro-radiation programme is anchored by stereotactic radiosurgery (SRS): single-session or short-course radiation delivered with sub-millimetre accuracy.
Brain tumours are masses of abnormal cells growing uncontrollably in the brain. Benign tumours don't invade surrounding tissue or spread — but inside the fixed space of the skull, even a benign tumour can compress and damage the brain as it grows. Malignant tumours invade and can be faster-growing, graded 1 to 4 by how aggressive they are.
Cancer can also spread to the brain from elsewhere in the body — secondary (metastatic) brain tumours, which in adults are more common than primary ones. They most often occur in people who have had cancer before.
Tumours are named for the cells they arise from: gliomas (including astrocytomas and glioblastoma), meningiomas, medulloblastomas, pituitary adenomas, germ cell tumours and CNS lymphomas among them. Each has a different outlook — and a different treatment plan. In Singapore, astrocytomas and glioblastoma multiforme are the most common primary types.
Symptoms usually relate to where in the brain the tumour sits, and to rising pressure inside the skull. Many can also be caused by other conditions — but persistent or progressive symptoms need assessment.
A first seizure in an adult always warrants brain imaging.
Especially headaches that are worse in the morning, or accompanied by nausea and vomiting.
Problems with balance, coordination or walking, or numbness and weakness on one side of the body.
Double vision or abnormal eye movements.
Difficulty with speech or understanding, or lapses in memory.
Changes in behaviour, personality or drowsiness noticed by you or those around you.
Modern neuro-imaging usually identifies a tumour's location and likely type before any procedure — and precise imaging is also what makes radiosurgery possible.
A clinical examination of vision, hearing, balance, coordination, strength and reflexes maps which brain regions are affected.
Contrast-enhanced MRI is the core investigation — defining the tumour's size, location and relationship to critical structures.
Where needed, tissue is obtained surgically or stereotactically to confirm the tumour type and grade.
For gliomas and selected tumours, molecular markers refine both prognosis and the treatment plan.
Most brain tumours arise without an identifiable cause — but some factors raise risk.
Exposure to high levels of ionising radiation, particularly during childhood, raises long-term risk.
Neurofibromatosis types 1 and 2, tuberous sclerosis, Von Hippel–Lindau disease and Li-Fraumeni syndrome are associated with brain tumours.
A family history of the genetic disorders above warrants awareness and, in some cases, surveillance.
A weakened immune system is associated with CNS lymphoma in particular.
A history of cancer elsewhere is the main risk factor for brain metastases — new neurological symptoms deserve prompt imaging.
Different tumour types cluster at different ages — some are most common in children, others in older adults.
Treatment is tailored to tumour type, grade and location — often combining surgery, radiation and systemic therapy. Radiosurgery has transformed what can be treated without opening the skull.
Single-session or short-course radiation delivered with sub-millimetre accuracy — for metastases, meningiomas, acoustic neuromas and selected tumours.
Precisely shaped multi-week courses for gliomas and tumours needing wider or gentler coverage.
Radiation combined with chemotherapy — the standard backbone for high-grade gliomas.
For selected cases — particularly children — AARO assesses and coordinates proton therapy with regional centres.
Every plan at AARO goes through detailed contouring, dose simulation, and independent physics review before a single beam is delivered. We do this so the radiation hits exactly the tissue that needs it — and avoids the healthy tissue around it.
Our medical physicists and radiation therapists collaborate on each plan — contouring tumour and organs-at-risk, simulating dose distribution, and independently checking every parameter before delivery.
Imaging before each fraction confirms the target's position to the millimetre — so tight margins stay safe, and healthy tissue stays out of the high-dose region.
Each treatment session takes 15–30 minutes. You'll lie on a precision treatment couch beneath the linear accelerator. Positioning lasers and daily imaging align you to within a millimetre of the planned position.
You won't feel the radiation as it's delivered. There's no anaesthesia, no recovery time, and no overnight stay. Most patients drive themselves home after the session and return to normal activities the same day.
AARO's neuro-radiation programme is led by sub-specialists in SRS for brain and skull-base tumours — the same consultant plans your treatment and follows you through it.
Book a 45–60 minute specialist consultation. We'll review your imaging and pathology, explain the options that apply to your case, and answer your questions.